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Background: There is limited knowledge on the prevalence of disease in total populations. Such studies have
historically been difficult to conduct but the development of health data registers has facilitated large-scale studies
on recorded diagnoses in entire regions. The aim of this study was to analyze the prevalence of diagnosis of six
common diseases in the Swedish capital region.
Methods: The study population included all living persons who resided in Stockholm County, Sweden, on
December 31st 2011 (N = 2 093 717). Information on all consultations between 2007 and 2011 was obtained from
primary health care, specialist outpatient care and inpatient care. Prevalence was defined as the proportion of
individuals with a recorded diagnosis of diabetes, depression, anxiety disorders, hypertension, asthma and chronic
obstructive pulmonary disease during the five year period, respectively. Analyses were done by age and gender.
Results: Hypertension had the highest five-year prevalence (12.2%), followed by depression (6.6%), diabetes mellitus
(6.2%), asthma (5.9%), anxiety disorders/phobia (4.8%), and COPD (1.8%). Diabetes was more common in men (5.3%
of women and 7.1% of men) while depression (8.7% in women and 4.4% in men) and anxiety (6.3% in women and
3.4% in men) were considerably more common in women. Smaller gender differences were also found for
hypertension (13.0% in women and 11.4% in men), asthma (6.4% in women and 5.4% in men) and COPD (2.1% in
women and 1.6% in men). Diabetes, hypertension and COPD increased markedly with age, whereas anxiety,
depression and asthma were fairly constant in individuals above 18 years. During one year of observation, more
than half of all patients had only been diagnosed in primary health care, with hypertension being the diagnosis
with the largest proportion of patients only identified in primary health care (70.6%).
Conclusion: The prevalence of common diseases in the population can be estimated by combining data gathered
during consecutive years from primary care, specialist outpatient care and inpatient care. However, accuracy of
disease prevalence is highly dependent on the quality of the data. The high prevalence of the six diagnoses
analysed in this study calls for preventive action to minimize suffering and costs to society.
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Epidemiological data on the prevalence and incidence of
diseases are valuable for making policy decisions and pro-
moting evidence-based disease prevention and manage-
ment. Prevalence can be assessed in several ways [1]. First,
by self-reported presence of diseases, which may contain
several uncertainties and result in different validity de-
pending on the studied diagnosis. Second, by using or
combining healthcare source data based on diagnosis re-
cords or on drug prescriptions but where individuals with-
out prescribed drugs will be lost. Third, by the use of two
or more data sources which could be combined by cap-
ture–recapture methods. Fourth, by population-based
screenings which will identify new cases but will have
lower validity in studies with low participation rates.
The establishment of the Swedish Hospital Discharge
Register in 1964 has facilitated studies on the prevalence
of diseases that require hospitalization [2,3]. The
Swedish Hospital Discharge Register includes all hospi-
talizations from 1987 onwards as well as all outpatient
consultations in hospitals from 2001 onwards. A number
of studies using this register have showed that the qual-
ity of its data is high and the register has been widely
used in many outcome studies [4,5].
In recent years, the development of electronic medical
records and administrative databases has facilitated stud-
ies on the prevalence and incidence of diseases in the
total population of different regions [6,7]. The main ad-
vantages of these registers are their full coverage of
healthcare consultations and that they are relatively easy
and inexpensive to use. Disadvantages include possible
bias in recording of diagnoses and variability in data
quality [8].
In Stockholm County, with a total population of more
than two million people, all diagnosis codes and reasons
for hospitalizations and consultations in primary health
care and specialist care are recorded and stored in a
large administrative database. This comprehensive data
collection enables epidemiological research in a large
unselected population cohort. The primary aim of this
study was to use these data to estimate the prevalence of
six common diagnoses, namely diabetes mellitus, depres-
sion, anxiety disorders, hypertension, asthma, and
chronic obstructive pulmonary disease (COPD) in the
total population of Stockholm County. Furthermore, the
distribution of these diagnoses across the different sec-
tors of the healthcare system, i.e. primary health care
(PC), specialist outpatient care (SOC) and inpatient care
(IC), recorded during the last year of observation, 2011,
was also determined.
Methods
Stockholm County has 2.1 million inhabitants, represen-
ting more than one-fifth of Sweden’s entire population.This area of Sweden includes the capital city of
Stockholm and several other cities and towns, as well as
large rural areas and a sparsely-populated archipelago.
The Stockholm County Council is responsible for finan-
cing primary and secondary health care, mainly through
taxes. Besides illegal immigrants, the general health in-
surance covers all residents. The majority of services are
provided by County-owned facilities. However, during
the last decade, more than 50% of primary care and ap-
proximately 8% of acute hospital care services have been
outsourced to private providers, either through tender
processes or managed patient choice [9]. Private pro-
viders are in contractual agreements with the County
and are legally obliged to record diagnoses and file re-
ports to the authorities just like public providers [10].
With the exception of very few private clinics that oper-
ate without subsidies in Stockholm, all consultations and
diagnoses are recorded and stored in the so-called VAL,
a central database. Besides consultations and diagnoses,
VAL compiles and stores data on healthcare utilization
and socio-demographics. The database has been used for
healthcare planning, practice remuneration and quality
assessment since the beginning of the 1980s, and its
content, registration routines, and supporting software
have improved over the years. It has previously been
used as a source of information in a number of scientific
studies, e.g. studies of hip fractures and its co-
morbidities [11,12], and Parkinson’s disease [13]. As an
indication for its accuracy and validity, VAL is used by
the Council for updating the National Patient Register
kept by the Swedish National Board of Health and Wel-
fare (NBHW) as well as the annual benchmarking re-
ports of the NBWH and the Swedish Association of
Local Authorities and Regions [4].
VAL has more than 99% coverage of hospital care.
More specifically, for each hospital stay the VAL data-
base contains a record of the provider unit, an encrypted
patient identification number, age and sex, the type and
length of the stay, up to ten diagnoses given, and ten in-
terventions (primarily surgical procedures, transfusions,
anaesthetic procedures). Since 1997, diagnoses have been
coded according to WHO’s International Classification
of Diseases, 10th edition (ICD-10) and procedures classi-
fied according to the Nordic Classification of Surgical
Procedures (NCSP).
Reporting utilization in specialized ambulatory care,
whether in hospital clinics or other locations, is also
mandatory since the late 1990s. This includes reporting
diagnoses (up to eight) for consultations by a physician,
date, type of visit, and certain procedures performed.
Also, nurse visits in homecare, visits to occupational or
physical therapists as well as most other healthcare pro-
fessionals are registered. VAL has more than 90% cover-
age of utilization in specialized ambulatory care.
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shorter history. In 2003, a project to extract information
on diagnoses (up to 15) from the electronic medical
records, when available, was launched. It has been esti-
mated that approximately 85% of all diagnoses in pri-
mary care are stored in VAL.
All data extracted from VAL were anonymised in the
current study.
Ethics
All data we handled were anonymized and none of the
numbers presented could be traced back to any individ-
ual. Management and analysis based on the VAL data-
base is a part of continuous quality control of healthcare
utilization in Stockholm county council. Research pro-
jects deemed as quality control are not subject to ethical
research board decisions in Sweden.
Study population
The present study population included all living persons
who resided in Stockholm County on December 31st
2011 (N = 2 093 717). Demography of Stockholm County
and number of doctor visits per person in 2011 are shown
in Table 1. Residents who died or moved from the region
during the five-year period of interest (2007–2011)
were excluded. Data on all healthcare consultations in
PC, SOC and IC between 2007 and 2011 were extracted
from VAL.
Major diagnosis groups
The following ICD codes were used to define each major
diagnosis group: diabetes mellitus E10-E14, depression
F32-F33, anxiety disorders F40-F41, hypertension I10-
I15, asthma J45-J46, and chronic pulmonary respiratory
disease (COPD) J41-J44, J47. The five-year prevalence of
each diagnosis was calculated by dividing the number of
persons with any of the diagnosis groups recorded at
least once between January 1st 2007 and December 31st
2011 with the total population number as for December
31st 2011. In a similar fashion, one-year prevalence of
each diagnosis (2011) was calculated by dividing theTable 1 The demography and number of doctor visits in Stoc
Age-groups Women 2011 Doctor visits per woman Men 2011
n % PC SOC n %
0-17 219612 20.8 1.62 0.77 231845 22.4
18-44 403774 38.2 1.69 1.24 410537 39.6
45-64 254622 24.1 2.13 1.49 255355 24.6
65-74 94586 9.0 3.11 2.06 87093 8.4
75-84 52699 5.0 5.20 2.64 37948 3.7
85- 31383 3.0 6.09 2.23 14263 1.4
Total 1056676 100 2.22 1.37 1037041 100
PC primary care, SOC specialist open care.number of persons with any of the diagnosis groups
recorded at least once during 2011 with the total popu-
lation number. The one-year- and five-year prevalence
figures may be viewed as a period prevalence, especially
for depression, and anxiety disorders.
Statistical methods
Standard descriptive statistics such as numbers and per-
centages out of the total population (N) were used.
Prevalence was presented as total/overall and was also
stratified by age and sex. Statistical analysis and data
management was performed using SAS software, version
9.3 (SAS Institute Inc., Cary, NC).
Results
Demography of Stockholm county
The population of Stockholm county was younger than
in the rest of the country, with only 14.2% of the popula-
tion being 65 years of age and older, and as many as
38.9% in the age group 18–44 years (Table 1).
Prevalence of diagnosed diabetes mellitus
In total, 5.3% of women and 7.1% of men in Stockholm
were diagnosed with diabetes during the five-year period
as shown in Table 2A. The highest prevalence was found
among persons aged 75–84 years, 23.1% among women
and 31.9% among men. In total, 56% of all patients iden-
tified with a diabetes diagnosis during a five-year period
were diagnosed during the last year of observation, 2011.
Prevalence of diagnosed depression
With the exception of children and adolescents (aged
0–17 years) where few were diagnosed (0.18%), a diagno-
sis of depression was common across all age groups in
both men and women as shown in Table 2B. The highest
five-year period prevalence of diagnosed depression was
found among women aged between 45–64 years (12.7%)
and men aged 85 years and older (10.8%). In total, 37%
of all patients identified with a depression diagnosis dur-
ing a five-year period were diagnosed during the last
year of observation, 2011.kholm county as of December 31, 2011
Doctor visits per man Total 2011 Doctor visits per person
PC SOC n % PC SOC
1.57 0.89 451457 21.6 1.59 0.83
0.94 0.73 814311 38.9 1.31 0.98
1.57 1.26 509977 24.4 1.85 1.38
3.02 2.22 181679 8.7 3.07 2.13
5.26 3.01 90647 4.3 5.23 2.79
6.46 2.89 45646 2.2 6.20 2.44
1.64 1.14 2093717 100 1.93 1.26
Table 2 The prevalence and the percentage in the population (Dec. 2011) of six diagnosis groups in 2007–2011 in
men, women and all inhabitants (total) in Stockholm county by age: A) diabetes mellitus (E10-E14), B) depression
(F32-F33), C) anxiety disorders/phobia (F40-F41) D) hypertension (I10-I15), E) asthma and F) (J45-J46) chronic
obstructive pulmonary disease (COPD) (J41-J44, J47)
Age-groups Women 2007-2011 Men 2007-2011 Total 2007-2011 Recorded diagnosis in 2011
alone and in relation to those
recorded between 2007-2011
N % n % n % n %
A) The prevalence of diagnosed diabetes mellitus.
0-17 676 0.3 852 0.4 1528 0.3 1229 80.4
18-44 4918 1.2 6221 1.5 11139 1.4 6700 60.1
45-64 16997 6.7 28212 11.0 45209 8.9 25290 55.9
65-74 14751 15.6 22230 25.5 36981 20.4 20828 56.3
75-84 12179 23.1 12123 31.9 24302 26.8 13228 54.4
85- 6417 20.4 3665 25.7 10082 22.1 4915 48.8
Total 55938 5.3 73303 7.1 129241 6.2 72190 55.9
B) The prevalence of diagnosed depression.
0-17 570 0.3 265 0.1 835 0.2 640 76.6
18-44 40762 10.1 20131 4.9 60893 7.5 23834 39.1
45-64 32315 12.7 17403 6.8 49718 9.6 17724 35.6
65-74 8470 9.0 4080 4.7 12550 6.9 4313 34.4
75-84 5848 11.1 2344 6.2 8192 9.0 2993 36.5
85- 3817 12.2 1121 7.9 4938 10.8 1592 32.2
Total 91782 8.7 45344 4.4 137126 6.6 51096 37.3
C) The prevalence of diagnosed anxiety disorders/phobia.
0-17 1035 0.5 639 0.3 1674 0.4 925 55.3
18-44 34551 8.6 18816 4.6 53367 6.6 21919 41.1
45-64 20148 7.9 11421 4.5 31569 6.2 11758 37.2
65-74 5265 5.6 2375 2.7 7640 4.2 2808 36.8
75-84 3380 6.4 1083 2.9 4463 4.9 1704 38.2
85- 2203 7.0 474 3.3 2677 5.9 982 36.7
Total 66582 6.3 34808 3.4 101390 4.8 40096 39.5
D) The prevalence of diagnosed hypertension.
0-17 115 0.1 121 0.1 236 0.1 71 30.1
18-44 5318 1.3 6047 1.5 11364 1.4 5715 50.3
45-64 41933 16.5 44822 17.5 86755 17.0 49645 57.2
65-74 38685 40.9 37568 43.1 76253 42.0 46191 60.6
75-84 31269 59.3 21367 56.3 52636 58.1 31832 60.5
85- 20498 65.3 8467 59.4 28965 63.5 16052 55.4
Total 137817 13.0 118392 11.4 256209 12.2 149506 58.4
E) The prevalence of diagnosed asthma.
0-17 17293 7.9 26184 11.3 43477 9.6 17924 41.2
18-44 21646 5.4 14950 3.6 36596 4.5 11945 32.6
45-64 15888 6.2 9167 3.6 25055 4.9 9142 36.5
65-74 6523 6.9 3327 3.8 9850 5.4 3793 38.5
75-84 3978 7.6 1691 4.5 5669 6.3 2217 39.1
85- 1945 6.2 637 4.5 2582 5.7 1023 39.6
Total 67273 6.4 55956 5.4 123229 5.9 46044 37.4
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Table 2 The prevalence and the percentage in the population (Dec. 2011) of six diagnosis groups in 2007–2011 in
men, women and all inhabitants (total) in Stockholm county by age: A) diabetes mellitus (E10-E14), B) depression
(F32-F33), C) anxiety disorders/phobia (F40-F41) D) hypertension (I10-I15), E) asthma and F) (J45-J46) chronic
obstructive pulmonary disease (COPD) (J41-J44, J47) (Continued)
E) The prevalence of diagnosed COPD.
0-17 335 0.2 434 0.2 769 0.2 455 59.2
18-44 1001 0.3 748 0.2 1749 0.2 721 41.2
45-64 6154 2.4 4685 1.8 10839 2.1 4910 45.3
65-74 6875 7.3 5226 6.0 12101 6.7 6190 51.2
75-84 5388 10.2 3741 9.9 9129 10.1 5027 55.1
85- 2569 8.2 1435 10.1 4004 8.8 2094 52.3
Total 22322 2.1 16269 1.6 38591 1.8 19397 50.3
The individuals with a reported diagnosis in 2011 are also shown in total and as percentage of the individuals with these diagnoses during the full
period 2007–2011.
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More women than men were diagnosed with anxiety
(6.3% vs. 3.4%) as shown in Table 2C. The highest preva-
lence was found among individuals aged between
18–44 years. When stratified by sex, 8.6% of women and
4.6% of men were diagnosed of anxiety/phobia recorded.
In total, 40% of all patients identified with an anxiety/
phobia diagnosis during a five-year period were diag-
nosed during the last year of observation, 2011.
Prevalence of diagnosed hypertension
As shown in Table 2D, 13.0% of women and 11.4% of
men in Stockholm a hypertension diagnosis was recor-
ded. An increase in diagnosed hypertension with advan-
cing age, ranging between 0.05% in children and 63.5%
in those aged 85 years and older was seen. Overall,
hypertension was more common in women than men.
In total, 58% of all patients identified with a hyperten-
sion diagnosis during a five-year period were diagnosed
during the last year of observation, 2011.
Prevalence of diagnosed asthma
As shown in Table 2E, diagnosed asthma was equally
common in men and women (6.4% vs 5.4%) and most
prevalent in children (9.6%). In total, 37% of all patients
identified with a asthma diagnosis during a five-year
period were diagnosed during the last year of observa-
tion, 2011.
Prevalence of diagnosed COPD
Diagnosed COPD was more prevalent among persons
aged 45 years and older with the highest prevalence in
men and women aged between 75–84 years (10.1%) as
shown in Table 2F. In total, 50% of all patients identified
with a COPD diagnosis during a five-year period were
diagnosed during the last year of observation, 2011.Distribution of diagnoses recorded across different
sectors of the healthcare system
The proportion of patients diagnosed with diabetes, de-
pression, anxiety disorders, hypertension, asthma and
COPD in PC, SOC, and/or IC during 2011 varied de-
pending on the diagnosis group. A majority of the pa-
tients in all six diagnosis groups were only identified in
only PC, with depression (56.5%) and hypertension
(70.6%) being the most commonly recorded diagnoses in
PC followed by diabetes mellitus (56.1%), asthma
(55.9%), COPD (53.6%), and anxiety/phobia (51.6%).
When comparisons in the distribution of all six diagno-
sis groups only in SOC were made, COPD was the most
commonly recorded diagnosis (33.8%). In IC, COPD was
the most common diagnosis recorded of the six (15%). It
was uncommon to have a diagnosis recorded in all three
health care sectors. Figures showing the distribution of
diagnoses recorded in PC, SOC and IC can be viewed,
Additional file 1: Figure S1.
Discussion
The current study estimates prevalence of diagnosed
common diseases in the total population in Stockholm
County, a region with more than 2 million inhabitants,
using recorded diagnoses in regional registers. The high
prevalence of the six common diagnosis groups reported
in this study calls for preventive action to be taken. Still,
there may be people who are not yet diagnosed and
population based health assessments have yielded indi-
viduals with newly diagnosed hypertension and diabetes
[1,14]. With more than 30% of men and 20% of women
aged between 75–84 years being diagnosed with diabetes
during a five-year period, considerable amounts of
health care resources will be needed. In addition, with
55% of all men and women in this age-group being
diagnosed with hypertension, a considerable burden
could be expected as this group would likely develop
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younger patients diagnosed with these conditions, subse-
quently developing complications, may also pose a chal-
lenge for the future.
The fact that the population is large enables stratifica-
tion by sex and age. Bearing in mind that approximately
20% of the inhabitants of Stockholm County are immi-
grants [15], the prevalence of common diseases in an
urban population of a Western country can be used as a
proxy for the prevalence of these diagnosed diseases in
similar populations of other regions or countries.
The overall prevalence of diagnosed COPD was 1.8%,
which was higher than a previous study of COPD preva-
lence in a population living in a rural region of Sweden
(1.2%) that had a similar design [7]. The difference in
prevalence could be due to more particles in the air in
Stockholm, higher proportion of smokers or a higher
awareness of COPD in recent years. Prevalence of
diagnosed COPD increased dramatically among persons
aged between 45–84 years whereas it decreased among
persons aged 85 years and over which may be explained
by the effect of smoking on longevity [16]. The opposite
was observed for the prevalence of anxiety /phobia
which was high in young adults aged between
18–44 years (6.6%). A recent Swedish study, where a
population based sample of 75-year-old persons was
interviewed over a period of one month, reported that
3.7% had generalized anxiety disorder according to ICD-
10 [17], which is consistent with the five-year prevalence
of 4.2% among persons aged between 65–74 years of the
total population of Stockholm County reported in this
study. Another Swedish study reported that as much as
24% of the Swedish population aged 20–64 years fulfilled
the criteria for anxiety and/or depression [18].
Diabetes is often regarded as equally common among
men and women, although a male preponderance has
been observed in those aged 45 years and over [19].
Wirehn et al. (2007) found an overall male preponder-
ance in diagnosed diabetes prevalence (4.6% in men vs
4.1% in women) [7] while in the current study an even
larger male predominance in diagnosed diabetes preva-
lence was found (7.1% in men vs 5.3% in women). In a
review (2001), Gale and Gillespie concluded that men
may be more susceptible to physical inactivity and obes-
ity than are women [20]. Overall prevalence of diag-
nosed diabetes was higher in the current study (6.2%)
than in earlier studies in Sweden (4.5%) [7,21]. One
explanation for the discrepancy may be the higher rate
of immigrants living in Stockholm County [22]. A
population-based study has shown that two thirds of the
60-year old diabetes patients are known [15].
The five-year period prevalence of diagnosed depres-
sion was high among adults, ranging between 9.0% and
12.2% in women and between 4.7 and 7.9% in men. Thehigher prevalence of depression among women than
among men has been reported previously [23], and may
be due to that women may be more active in seeking
health care when they experience depressive symptoms.
Also, the prevalence of diagnosed depression was lower
among individuals younger than 65 years of age than
those aged between 65–74 years which may be explained
by lack of incentive to be sick-listed in the years follow-
ing retirement. Persons with depression have been
shown to have a higher risk for somatic diseases than
non-depressed individuals [24], which may have had an
effect on the diagnosed prevalence of all diagnosis
groups in women in this study.
Studies of hypertension in the US have shown that the
prevalence in the adult population (18 years of age and
over) was nearly 30% [25,26], which was higher than that
we reported in this study (12.2%) implying there may be
a large number of undiagnosed individuals in the total
population of Stockholm County. This is in agreement
with a screening study of 60 year-old persons from
Stockholm which showed that newly diagnosed hyper-
tension was more prevalent than already diagnosed
hypertension [14]. The prevalence of hypertension is
highly dependent on age [27], which was consistent with
our findings. It has been previously shown that preva-
lence of hypertension is lower in women than in men
until menopause, after which prevalence increases and
reach levels observed in men [28,29]. Large scale
population-based investigations are, however, still sparse
and the true prevalence in the population is therefore
not fully known, making the findings of the current valu-
able. Moreover, hypertension awareness, treatment and
control vary greatly in different studies from around the
world [30], and in populations of different countries
studied following the same methodology [31].
In contrast to the other diagnosis groups, asthma
appeared to affect children the most. Furthermore, diag-
nosed asthma was more common in boys than in girls
and in women than men. The prevalence rates and
gender differences are consistent with a recent review
estimating the overall prevalence of asthma at 5-7%
in the total population and 8-10% in children [32]. Previ-
ous studies have also shown that women with asthma
seek care more often than do men [33,34]. Asthma in
children is often associated with rhinitis and eczema as
well. The BAMSE birth cohort reported that 58% of
12 year-old children had one, two or all these three
conditions at some time [35].
Our study revealed important information on the
prevalence of diagnosed common diseases in the popula-
tion. It could be useful for the planning of healthcare
needs, resource allocation and disease prevention.
Access to electronic longitudinal data from primary
healthcare may also provide unique opportunities for
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search [2]. Some benefits include availability of large
populations at a relatively low cost and shortening the
time necessary to identify a sufficient number of patients
with a specific diagnosed disease. They may also enable
studies of patient groups that are usually omitted from
randomized controlled trials, i.e. patients with co-
morbidities [36]. Recently, prescription data on individ-
uals, using the same encrypted identification numbers as
data from VAL, have been added to the database. This
enables a unique possibility to link drug prescriptions to
diagnoses and patient outcome.
It is important to emphasize that the frequency and
diagnosis coverage may vary between different physi-
cians, primary health care centres and diagnosis group
[37]. Additionally, the reporting of diagnoses may
change along with changes in the healthcare reimburse-
ment system, however, no major changes occurred in
the region during the course of this study. To achieve
better prevalence estimates, data from PC, SOC and IC
could be used together and from consecutive years [7].
The applicability of our method may also vary between
different settings. Health care systems vary widely across
different regions and countries. More patients in
Stockholm receive their care from specialists other than
GPs, due to an proportionally smaller primary care sec-
tor compared with the UK [38].
Inclusion of only those who were alive at the end of
the study period has likely introduced a survival bias as
individuals who died during the five-year period were
likely to have used considerably more healthcare re-
sources than average. Consequently, the prevalence of
diseases that are common among older persons, such as
COPD, may have been underestimated. However, this is
not a problem if the data are interpreted as point
prevalences.
Most of the conditions encountered in PC are readily
treatable, for example acute infections and inflammatory
conditions, whereas others are chronic or relapsing and
often non-acute such as diabetes mellitus, depression,
anxiety disorders, hypertension, asthma, and chronic ob-
structive pulmonary disease (COPD). The diagnostic ac-
curacy may also vary, depending on the disorder and the
diagnostic criteria applied. For diabetes, highly valid
diagnostic criteria make the disease easy to identify [39].
In the current study we did not make a distinction be-
tween Type I and Type II diabetes, as one of the most
commonly used diagnosis codes in primary care is dia-
betes mellitus not otherwise specified. However, it is well
known than Type II diabetes is more prevalent than
Type I diabetes. While data on asthma, hypertension
and diabetes diagnoses the diagnostic accuracy could be
expected to be of high validity, data on COPD, anxiety/
phobia, and depression may not be as straightforward.Stockholm County has seen more people moving in
than moving out. Consequently, a slight underestimation
in prevalence of the diagnostic groups may be expected
as new inhabitants may have not yet lived in Stockholm
long enough to have diagnoses recorded during the five-
year period of interest. This may hold true for individ-
uals aged between 18–44 years. However, this effect may
have been balanced out by excluding those who died
during the same period.
Conclusion
In conclusion, the prevalence of known and diagnosed
diseases can be estimated using administrative health
data registers. Whether a diagnosis is evaluated and
recorded in primary care, specialist outpatient care or
inpatient care, the diagnosed prevalence estimates are
highly dependent on the quality of the diagnosis. It takes
further validation studies to investigate if there are great
discrepancies in diagnosis accuracy between different
levels of care, and how that influences our overall know-
ledge of the existence of various patient groups. The
high prevalence of the six diagnoses analysed in this
study calls for preventive action to be taken to minimize
suffering and costs to society.
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